Maximum quantity allowed is 999
Please select the quantity
CAS RN: 99469-99-5 | Product Number: E0928
2-(3-Ethoxy-4-ethoxycarbonylphenyl)acetic Acid
Purity: >98.0%(GC)(T)
Synonyms:
- Ethyl 4-Carboxymethyl-2-ethoxybenzoate
- 4-Carboxymethyl-2-ethoxybenzoic Acid Ethyl Ester
Product Documents:
Size | Unit Price | Shanghai | Tianjin | Japan* |
---|---|---|---|---|
5G |
¥430.00
|
1 | Contact Us | 2 |
25G |
¥2,030.00
|
Contact Us | Contact Us | 6 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
Product Number | E0928 |
Purity / Analysis Method | >98.0%(GC)(T) |
Molecular Formula / Molecular Weight | C__1__3H__1__6O__5 = 252.27 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 99469-99-5 |
Reaxys Registry Number | 8210175 |
PubChem Substance ID | 253659996 |
MDL Number | MFCD08704233 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(GC) | min. 98.0 % |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 78.0 to 82.0 °C |
NMR | confirm to structure |
Properties (reference)
Melting Point | 80 °C |
Solubility (soluble in) | Methanol |
GHS
Pictogram | |
Signal Word | Danger |
Hazard Statements | H318 : Causes serious eye damage. |
Precautionary Statements | P280 : Wear eye protection/ face protection. P305 + P351 + P338 + P310 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. |
Related Laws:
Transport Information:
Customs Control Conditions (Q) |
Application
A Synthetic Intermediate of Repaglinide
This product is used for the synthesis of a carbamoylmethyl benzoic acid derivative, repaglinide [R0179] which is a fast-acting insulin-releasing agent used for the treatment of type 2 diabetes.
References
- Repaglinide and Related Hypoglycemic Benzoic Acid Derivatives
- Studies on diastereofacial selectivity of a chiral tert-butanesulfinimines for the preparation of (S)-3-methyl-1-(2-piperidin-1-yl-phenyl)butylamine for the synthesis of repaglinide
- Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.